Gables Capital Management Inc. Johnson & Johnson Transaction History

Gables Capital Management Inc.

$189 Million
Q2 2024

A detailed history of Gables Capital Management Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Gables Capital Management Inc. holds 13,437 shares of JNJ stock, worth $2.21 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

13,437

Previous 12,532 7.22%

Holding current value

$2.21 Million

Previous $1.98 Million 0.96%

% of portfolio

1.04%

Previous 1.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$144.38 - $157.78 $130,663 - $142,790	905 Added 7.22%	13,437 $1.96 Million
Q1 2024 May 03, 2024	SELL	$155.22 - $162.74 $38,805 - $40,685	-250 Reduced 1.96%	12,532 $1.98 Million
Q4 2023 Feb 07, 2024	BUY	$145.6 - $158.88 $30,721 - $33,523	211 Added 1.68%	12,782 $2 Million
Q3 2023 Nov 02, 2023	SELL	$155.75 - $174.48 $31,150 - $34,896	-200 Reduced 1.57%	12,571 $1.96 Million
Q1 2023 May 03, 2023	SELL	$151.05 - $180.26 $9,063 - $10,815	-60 Reduced 0.47%	12,771 $1.98 Million
Q4 2022 Feb 03, 2023	BUY	$160.2 - $179.79 $8,009 - $8,989	50 Added 0.39%	12,831 $2.27 Million
Q3 2022 Oct 31, 2022	BUY	$161.33 - $179.52 $4,839 - $5,385	30 Added 0.24%	12,781 $2.09 Million
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $4,677 - $5,190	30 Added 0.24%	12,751 $2.18 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $30,685 - $34,099	-190 Reduced 1.47%	12,721 $2.05 Million
Q2 2021 Aug 03, 2021	SELL	$159.48 - $171.07 $1.25 Million - $1.34 Million	-7,812 Reduced 37.7%	12,911 $2.13 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $76,535 - $85,240	-500 Reduced 2.36%	20,723 $3.41 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $37,762 - $41,380	-269 Reduced 1.25%	21,223 $3.16 Million
Q2 2020 Jul 30, 2020	SELL	$128.81 - $155.51 $70,845 - $85,530	-550 Reduced 2.5%	21,492 $3.02 Million
Q1 2020 May 07, 2020	BUY	$111.14 - $153.99 $94,469 - $130,891	850 Added 4.01%	22,042 $2.89 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $73,312 - $84,203	-575 Reduced 2.64%	21,192 $3.09 Million
Q3 2019 Oct 30, 2019	BUY	$126.95 - $142.14 $137,613 - $154,079	1,084 Added 5.24%	21,767 $2.82 Million
Q1 2019 Apr 30, 2019	SELL	$125.72 - $139.79 $153,378 - $170,543	-1,220 Reduced 5.57%	20,683 $2.89 Million
Q4 2018 Feb 08, 2019	SELL	$122.84 - $147.84 $83,531 - $100,531	-680 Reduced 3.01%	21,903 $2.83 Million
Q3 2018 Nov 05, 2018	SELL	$121.58 - $142.88 $30,395 - $35,720	-250 Reduced 1.09%	22,583 $0
Q2 2018 Aug 03, 2018	SELL	$119.4 - $131.76 $15,283 - $16,865	-128 Reduced 0.56%	22,833 $2.76 Million
Q1 2018 May 17, 2018	BUY	$125.1 - $148.14 $2.87 Million - $3.4 Million	22,961 New	22,961 $2.94 Million

Others Institutions Holding JNJ

# of Institutions

4,157

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $430B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Account

Gables Capital Management Inc. Johnson & Johnson Transaction History